{"title":"A Focal \"Inferno Sign\" With an Aberrant Innominate Artery Feeder: A Thyroid Arteriovenous Malformation Mimicking Malignancy in a Young Woman.","authors":"Ampuriire Nyakubaho, Brendah Ayikoru, Monica Acen Okwir, Juliet Nyakake, Joseph Ochom, Deborah Babirye","doi":"10.1155/crie/6016666","DOIUrl":"https://doi.org/10.1155/crie/6016666","url":null,"abstract":"<p><p>Arteriovenous malformations (AVMs) of the thyroid gland are exceptionally rare, with only 11 cases identified in our review of the literature. They are clinically important because their hypervascularity on imaging can raise suspicion of malignancy, and biopsy or surgery may provoke life-threatening hemorrhage. We present a case of a 30-year-old female with a decade-long history of anterior neck swelling that recently became painful and enlarged. Ultrasound demonstrated a well-defined hypoechoic right-lobe nodule with marked color Doppler hypervascularity (described here as a focal \"inferno sign\"), a tangled vascular nidus, low-resistance arterial flow in the dominant feeding vessel, and early arterialization of the draining vein; together, these findings suggested arteriovenous shunting. Computed tomography angiography (CTA) characterized the lesion as a 1.0 cm × 0.9 cm intensely enhancing nodule supplied by an aberrant artery arising directly from the innominate artery, immediately medial to the origin of the right common carotid artery, with drainage into the right internal jugular vein. A radiological diagnosis of thyroid AVM was made without histopathological or angiographic confirmation, and fine-needle aspiration (FNA) was avoided because of the bleeding risk. The patient was referred for multidisciplinary management but was lost to follow-up. To our knowledge, this is the first reported thyroid AVM supplied by an innominate artery branch, a variant relevant to surgical and endovascular planning. Thyroid AVM should be considered in the differential diagnosis of hypervascular thyroid nodules, and CTA is valuable for mapping its vascular anatomy noninvasively.</p>","PeriodicalId":9621,"journal":{"name":"Case Reports in Endocrinology","volume":"2026 ","pages":"6016666"},"PeriodicalIF":0.8,"publicationDate":"2026-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13770265/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149417139","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Beyond Fingersticks: Continuous Glucose Monitoring for Inpatient Glycemic Management in a Patient With Type 1 Diabetes and Castleman Disease-A Case Report.","authors":"Cristian D Armas, Amna Kamran, Manasi Shah","doi":"10.1155/crie/1901927","DOIUrl":"10.1155/crie/1901927","url":null,"abstract":"<p><p>Continuous glucose monitoring (CGM) provides real-time interstitial glucose data and may detect glycemic excursions missed by point-of-care blood glucose (POC BG) testing. Inpatient evidence remains limited, especially in patients with severe dermatologic disease limiting POC access. We report a 22-year-old male with poorly controlled type 1 diabetes and Castleman disease who presented with diffuse pruritic hyperpigmented lesions, mucositis, and nail dystrophy, precluding reliable fingerstick monitoring. During his several-month hospitalization, he received high-dose corticosteroids, rituximab, and intravenous immunoglobulin, with marked glycemic variability due to steroid-induced hyperglycemia, variable intake, and intermittent refusal of care. A Dexcom G7 CGM was initiated to facilitate glucose monitoring, and a single earlobe capillary glucose measurement was obtained at the time of CGM initiation as a reference blood glucose value. CGM data were manually integrated into the electronic medical record (EMR) by nursing staff and used to support insulin titration. Most serum and POC BG measurements did not show major differences from corresponding CGM values. During the first month, time in range (TIR) was 30%, time below range was 2%, and glucose management indicator (GMI) was 8.9%. CGM was used for nearly 3 months during hospitalization, facilitating CGM when POC testing was challenging. The patient later developed respiratory failure, likely due to bronchiolitis obliterans, and died. CGM enabled continuous monitoring when fingersticks were not feasible, supporting insulin adjustment in complex inpatient hyperglycemia. Implementation requires multidisciplinary coordination and validation protocols.</p>","PeriodicalId":9621,"journal":{"name":"Case Reports in Endocrinology","volume":"2026 ","pages":"1901927"},"PeriodicalIF":0.8,"publicationDate":"2026-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13768857/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149402219","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Rebecca Zerbinatti Pereira, Ylana Walleska Santos Santana, Gabriel Monti, Virgínia Oliveira Fernandes, Renan Magalhães Montenegro, Lenita Zajdenverg, Carlos Antonio Negrato
{"title":"Phenotypic Presentation of Atypical Familial Partial Lipodystrophy in a Patient With a Rare Mutation in the <i>LMNA</i> Gene: A Case Report and Literature Review.","authors":"Rebecca Zerbinatti Pereira, Ylana Walleska Santos Santana, Gabriel Monti, Virgínia Oliveira Fernandes, Renan Magalhães Montenegro, Lenita Zajdenverg, Carlos Antonio Negrato","doi":"10.1155/crie/8775312","DOIUrl":"10.1155/crie/8775312","url":null,"abstract":"<p><strong>Background: </strong>Variants in the <i>LMNA</i> gene are classically associated with familial partial lipodystrophy type 2 (FPLD2/Dunnigan syndrome). However, certain mutations produce severe multisystemic phenotypes that may mimic congenital generalized lipodystrophy (CGL). This case adds to the literature by delineating the distinct syndromic expression of the <i>LMNA</i> p.Arg349Trp variant and underscoring the need for early recognition to guide cardiovascular and renal surveillance.</p><p><strong>Clinical findings: </strong>A 41-year-old woman presented to a specialized diabetes clinic serving low-income populations with severe lipoatrophy of the face and limbs, relative preservation of truncal adiposity, refractory diabetes, severe hypertriglyceridemia, arterial hypertension, and heart failure. Due to the pattern of lipodystrophy, severe systemic involvement, and absence of compensatory cervicofacial fat accumulation, CGL (Berardinelli-Seip syndrome) was initially suspected.</p><p><strong>Diagnoses interventions and outcomes: </strong>Next-generation sequencing identified a heterozygous pathogenic <i>LMNA</i> variant, c.1045C>T (p.Arg349Trp). At baseline, the patient presented with established proteinuric nephropathy, severe hypertriglyceridemia, and cardiovascular disease. Following multidisciplinary care and an optimized pharmacological protocol, transient improvement in metabolic and glycemic profiles was achieved. However, despite good therapeutic response, socioeconomic barriers disrupted access to high-cost medications, and she deteriorated to cardiovascular and hepatic failure, dying from cardiogenic shock and sepsis of abdominal origin in less than 2 years of follow-up.</p><p><strong>Conclusion: </strong>This case highlights the high clinical severity of the <i>LMNA</i> p.Arg349Trp variant. Recognizing it as a distinct syndromic entity is crucial to prevent diagnostic delays, enabling timely cardiovascular and renal surveillance, particularly in resource-limited settings where treatment interruptions can have fatal consequences.</p>","PeriodicalId":9621,"journal":{"name":"Case Reports in Endocrinology","volume":"2026 ","pages":"8775312"},"PeriodicalIF":0.8,"publicationDate":"2026-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13768853/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149402220","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Cesar Alfonso Gomez-Fontalvo, Silvia Alejandra Díaz-Jaimes, María Paula Rangel-Villamizar, Diego Augusto Moreno-Diaz, Rafael Castellanos-Bueno
{"title":"Embolization of Thyroid Arteries as a Bridge Therapy Before Thyroidectomy in a Patient With Thyrotoxicosis: Case Report.","authors":"Cesar Alfonso Gomez-Fontalvo, Silvia Alejandra Díaz-Jaimes, María Paula Rangel-Villamizar, Diego Augusto Moreno-Diaz, Rafael Castellanos-Bueno","doi":"10.1155/crie/8194736","DOIUrl":"10.1155/crie/8194736","url":null,"abstract":"<p><p>Thyroid artery embolization (TAE) is a minimally invasive technique that induces selective ischemic necrosis of the thyroid parenchyma, thereby reducing thyroid hormone synthesis with few associated complications. Successful cases of TAE as a bridge therapy before total thyroidectomy in patients with refractory thyrotoxicosis are rare. We present the case of a 36-year-old man with a history of Graves' disease and poor adherence to medical therapy who presented with clinical features of thyrotoxicosis. On physical examination, he exhibited active moderate-to-severe orbitopathy (EUGOGO classification; clinical activity score 5/7) and a grade III goiter, reflecting advanced and poorly controlled disease. Paraclinical findings revealed markedly elevated free T4 levels and suppressed TSH. The diagnosis of uncontrolled hyperthyroidism was made, with a Burch-Wartofsky score of 40 points, indicating an impending thyroid storm. Medical therapy at maximally tolerated doses did not result in a complete clinical response; therefore, a total thyroidectomy was planned, preceded by therapeutic plasma exchange (TPE). Due to intolerance to TPE, TAE was performed as a bridge therapy, followed by total thyroidectomy without complications. The patient was discharged with a resolution of symptoms and progressive normalization of thyroid hormone levels. TAE may represent a valuable bridging therapy before total thyroidectomy in selected patients with severe thyrotoxicosis due to Graves' disease who are refractory to or unsuitable for conventional therapies.</p>","PeriodicalId":9621,"journal":{"name":"Case Reports in Endocrinology","volume":"2026 ","pages":"8194736"},"PeriodicalIF":0.8,"publicationDate":"2026-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13700110/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149262962","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Rabih A Noun, Ossama Sajeh Maadarani, Zouheir I Bitar
{"title":"Capivasertib-Associated Diabetic Ketoacidosis With Concurrent Myocardial Injury in a Patient With Pre-Existing Coronary Artery Disease.","authors":"Rabih A Noun, Ossama Sajeh Maadarani, Zouheir I Bitar","doi":"10.1155/crie/6940757","DOIUrl":"10.1155/crie/6940757","url":null,"abstract":"<p><p>Capivasertib is a serine/threonine kinase AKT (AKT1-3) inhibitor, disrupting phosphorylation of AKT substrates. When combined with fulvestrant, it is approved for hormone receptor-positive advanced breast cancer. Capivasertib therapy frequently causes hyperglycemia, including diabetic ketoacidosis (DKA). Ensure glycemic control before initiation and maintain ongoing blood glucose monitoring to reduce the risk of this potentially fatal complication. We present a case of metastatic breast cancer with initially controlled blood glucose who developed ketoacidosis and myocardial infarction during capivasertib therapy.</p>","PeriodicalId":9621,"journal":{"name":"Case Reports in Endocrinology","volume":"2026 ","pages":"6940757"},"PeriodicalIF":0.8,"publicationDate":"2026-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13655374/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149166058","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Lorenzo Taglia, Alessandra Guercio, Silvia Migliari, Angela Vazzana, Riccardo C Bonadonna, Livia Ruffini, Alessandra Dei Cas
{"title":"Persistent Hyperinsulinemic Hypoglycemia After Insulinoma Surgery: Diagnostic Impact of GLP-1 Receptor PET/CT After Negative Conventional Imaging.","authors":"Lorenzo Taglia, Alessandra Guercio, Silvia Migliari, Angela Vazzana, Riccardo C Bonadonna, Livia Ruffini, Alessandra Dei Cas","doi":"10.1155/crie/7874466","DOIUrl":"10.1155/crie/7874466","url":null,"abstract":"<p><strong>Background: </strong>Localization of recurrent or residual insulinoma may be particularly challenging in postoperative setting, especially in the presence of postoperative anatomical distortion and inconclusive conventional imaging.</p><p><strong>Case presentation: </strong>A 71-year-old man developed recurrent endogenous hyperinsulinemic hypoglycemia following apparently curative surgical enucleation of a pancreatic insulinoma. The postoperative course was complicated by intra-abdominal hemorrhage and pseudocyst formation, resulting in marked anatomical distortion. Despite persistent biochemical evidence of insulinoma recurrence, serial contrast-enhanced computed tomography (CT) and <sup>68</sup>Ga-DOTATOC PET/CT failed to identify residual disease. Subsequent glucagon-like peptide-1 receptor (GLP-1R) imaging with <sup>68</sup>Ga-NODAGA-Exendin-4 PET/CT demonstrated focal tracer uptake in the pancreatic head, highly suggestive of recurrent or residual insulinoma. Endoscopic ultrasound (EUS) subsequently confirmed a small lesion in the uncinate process, which was successfully treated with EUS-guided radiofrequency ablation (EUS-RFA). Following the procedure, hypoglycemic episodes resolved, with normalization of glucose, insulin, and C-peptide levels and no signs of recurrence at follow-up.</p><p><strong>Conclusion: </strong>This case highlights the clinical value of GLP-1 receptor PET/CT for localizing insulinoma in the context of negative conventional or somatostatin receptor (SSTR)-based imaging. Accurate functional localization may directly guide minimally invasive therapeutic interventions and help avoid high-risk reoperative pancreatic surgery.</p>","PeriodicalId":9621,"journal":{"name":"Case Reports in Endocrinology","volume":"2026 ","pages":"7874466"},"PeriodicalIF":0.8,"publicationDate":"2026-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13647209/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149135036","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"An Infant With Hyponatremia, Hyperkalemia, and Faltering Growth: A Case Report.","authors":"Felicia Cooper, Heather Fagan, Sindy Villacres, Pamela Ellsworth, Shilpa Gurnurkar","doi":"10.1155/crie/1964629","DOIUrl":"10.1155/crie/1964629","url":null,"abstract":"<p><p>Infants presenting with hyponatremia and hyperkalemia routinely engage clinician concern for congenital adrenal hyperplasia (CAH), a set of disorders resulting in difficulty producing glucocorticoids, mineralocorticoids, and sex steroids in the adrenal glands. However, we present the case of an infant with classic CAH-like symptoms, a negative newborn screen, and clinical features inconsistent with the diagnosis of CAH. Ultimately, the patient was diagnosed with pseudohypoaldosteronism (PHA), a condition in which aldosterone is unable to activate its receptor in the kidney. Notably, he also exhibited an uncommon complication of a left external iliac thrombus. Infants with hyponatremia and hyperkalemia without an immediately identifiable cause should be screened for urinary tract infection (UTI) and urinary tract malformations, and infants with severe urinary tract abnormality or malformation should have electrolytes monitored. This recommendation stems from the increased susceptibility of developing PHA in the setting of UTI without genitourinary tract malformation.</p>","PeriodicalId":9621,"journal":{"name":"Case Reports in Endocrinology","volume":"2026 ","pages":"1964629"},"PeriodicalIF":0.8,"publicationDate":"2026-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13613423/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149058468","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Recurrent Euglycemic Diabetic Ketoacidosis Weeks After SGLT2 Inhibitor Cessation: A Case Report.","authors":"Celine Mansour, Emile Katrib, Myriam Mansour, Mirna Fares","doi":"10.1155/crie/9610048","DOIUrl":"10.1155/crie/9610048","url":null,"abstract":"<p><p>Euglycemic diabetic ketoacidosis (EDKA) is a complication of sodium-glucose cotransporter-2 (SGLT2) inhibitors that is being increasingly documented. It is challenging to diagnose, especially in critically ill patients because hyperglycemia is absent or mild. We report the case of a 71-year-old man with type 2 diabetes mellitus previously treated with dapagliflozin, which had been discontinued 2 weeks before presentation, who was admitted for tracheostomy and percutaneous endoscopic gastrostomy (PEG) placement in the context of a neurodegenerative disorder. On postoperative day 2, he was transferred to the intensive care unit (ICU) for aspiration pneumonia complicated by septic shock. He subsequently experienced recurrent episodes of high anion gap metabolic acidosis associated with positive ketonuria and relative euglycemia. The initial episode was interpreted as mixed septic lactic acidosis and SGLT2 inhibitor-associated EDKA, whereas later episodes were more consistent with isolated recurrent EDKA. Management consisted of treatment of the underlying septic shock, and repeated courses of fixed intravenous (IV) insulin infusions to close the anion gap while maintaining euglycemia. This case demonstrates the importance of suspecting EDKA, especially in critically ill patients on SGLT2 inhibitors who present with unexplained high anion gap metabolic acidosis, even when lactic acidosis is present. Early diagnosis and treatment are essential to prevent complications and relapse.</p>","PeriodicalId":9621,"journal":{"name":"Case Reports in Endocrinology","volume":"2026 ","pages":"9610048"},"PeriodicalIF":0.8,"publicationDate":"2026-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13613943/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149058551","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Diazoxide-Responsive Congenital Hyperinsulinism in a Preterm Infant With Homozygous <i>ABCC8</i> Mutation: A Case Report.","authors":"Prerana Kansakar, Grisha Gurung, Sadikshya Bhandari, Kriti Shrestha, Bhumika G C, Shreya Thapa, Rasik Acharya","doi":"10.1155/crie/7968566","DOIUrl":"https://doi.org/10.1155/crie/7968566","url":null,"abstract":"<p><strong>Introduction: </strong>Congenital hyperinsulinism (CHI) is characterized by inappropriate insulin secretion resulting in persistent neonatal hypoglycemia. CHI is often linked to mutations in the <i>ABCC8</i> and <i>KCNJ11</i> genes and can lead to persistent hypoglycemia, seizures, and neurological injury, making early diagnosis and management essential.</p><p><strong>Case report: </strong>We describe a late-preterm Nepalese infant born at 34 weeks and 5 days of gestation, weighing 5.26 kg, to a 32-year-old gravida four nondiabetic mother. The infant developed significant hypoglycemia just 2 h after birth. Despite a glucose infusion rate (GIR) of 12 mg/kg/min, the infant had persistent hypoglycemia. A critical sample confirmed hyperinsulinism, prompting treatment with octreotide, intravenous (IV) GIR of 17 mg/kg/min and later diazoxide. Due to limited IV access, a continuous enteral GIR of 9 mg/kg/min was administered through an orogastric (OG) tube. Genetic testing revealed a homozygous pathogenic p.Arg1214Gln mutation in the <i>ABCC8</i> gene, and <sup>18</sup>F-DOPA PET-CT (2-deoxy-2-[fluorine-18]fluoro-D-glucose positron emission computed tomography) showed diffuse pancreatic uptake. At 5 months, interruption of diazoxide therapy led to a hypoglycemic seizure (blood glucose level: 29 mg/dL), which resolved after the treatment resumed. Despite the typical association of homozygous <i>ABCC8</i> mutations with diazoxide nonresponsiveness, this infant achieved sustained glycemic control on diazoxide. On subsequent follow-ups, the child remains stable and continues to achieve normal developmental milestones.</p><p><strong>Conclusion: </strong>Early recognition and timely management are crucial in effective management of CHI. This case shows rare diazoxide responsiveness in homozygous <i>ABCC8</i> mutation. This case suggests that a carefully monitored therapeutic trial of diazoxide may still be reasonable in selected patients with homozygous <i>ABCC8</i> mutations before concluding complete medical unresponsiveness.</p>","PeriodicalId":9621,"journal":{"name":"Case Reports in Endocrinology","volume":"2026 ","pages":"7968566"},"PeriodicalIF":0.8,"publicationDate":"2026-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13599591/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149036594","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Don Asiri Abeysiriwardana, Pahala Gamage Nipuna Jeewantha Dias, Warsha Dilhani De Zoysa, Arosha Sampath Dissanayake
{"title":"Exploring Thyrotoxic Hypercalcaemia Through Two Cases: A Myriad of Uncertainties.","authors":"Don Asiri Abeysiriwardana, Pahala Gamage Nipuna Jeewantha Dias, Warsha Dilhani De Zoysa, Arosha Sampath Dissanayake","doi":"10.1155/crie/3906797","DOIUrl":"10.1155/crie/3906797","url":null,"abstract":"<p><p>Hypercalcaemia is a recognised complication of thyrotoxicosis usually related to increased bone resorption. However, coexistent hyperphosphataemia is uncommon and may create diagnostic uncertainty. It is postulated that serum calcium and phosphate levels rise due to high bone turnover and increased renal reabsorption of phosphate in response to excess thyroxine. Hypercalcaemia may also alter the clinical presentation of thyrotoxicosis, making both diagnosis and management challenging. We report two patients with this unusual biochemical presentation. The first patient was a 69-year-old woman who presented with body aches, lethargy, low mood, constipation, polyuria, and proximal muscle weakness for 2 months. The second was a 56-year-old woman who presented with palpitations, anxiety, tremulousness, dyspnoea, dysphagia, and headache for 4 months. Both had multinodular goitres (MNGs) without eye disease. Their TSH levels were undetectably low with extremely high free T4 levels. Serum calcium and phosphate levels were high in both patients. ALP levels were mildly elevated, vitamin D levels were deficient or insufficient, and parathyroid hormone (PTH) levels were low-normal. DXA scans revealed severe osteoporosis. Both patients improved clinically and biochemically with adequate intravenous hydration, frusemide, carbimazole, propranolol, and bisphosphonates. The second patient underwent a successful left thyroid lobectomy, while the first patient remained well on medical treatment. Unexplained hypercalcaemia and hyperphosphataemia should alert the clinicians to the possibility of underlying thyrotoxicosis. Prompt recognition and management is essential to prevent bone loss, correct metabolic abnormalities, and avoid complications. Clinicians should also consider the possibility of hypercalcaemia associated with thyroid dysfunction in patients presenting with nonspecific symptoms such as fatigue, constipation, proximal weakness, polyuria, or mood changes.</p>","PeriodicalId":9621,"journal":{"name":"Case Reports in Endocrinology","volume":"2026 ","pages":"3906797"},"PeriodicalIF":0.8,"publicationDate":"2026-09-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13591542/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149015603","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}